NCT06190899 2025-03-21Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate CancerCelcuity IncPhase 1/2 Recruiting54 enrolled
NCT04737109 2023-11-13ADDItionBig Ten Cancer Research ConsortiumPhase 1/2 Terminated6 enrolled 9 charts
NCT01317641 2017-03-29Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate CancerOrion Corporation, Orion PharmaPhase 1/2 Completed136 enrolled 28 charts